Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the ...

AARISE PHARMACEUTICALS, HARIDWAR (UK) is a fast-growing pharmaceutical company that has made a strong impact in the healthcare industry within just one year of its establishment. Despite being a ...

Somehow Washington regards the industry, which has saved and improved tens of millions of lives, as a villain.

Rhythm Pharmaceuticals received an orphan-drug designation from Japan's Ministry of Health, Labour and Welfare for its treatment for a certain type of obesity.

The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...

US pharmaceutical giants hope the protectionist Trump administration will force Australia to increase the price it pays for ...

The products will be manufactured at the Verna, Goa facility, and will be marketed & distributed in Australian markets ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

REYOBIQ™ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and ...

Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India after receiving regulatory approval. With rising ...

Shares of OptiNose (NASDAQ:OPTN) climbed ~61% in the premarket on Thursday after the specialty pharmaceutical company agreed ...

The stringent action is meant to prevent criticism of quality of drugs produced in the country and to prevent any non-tariff ...